Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large <scp>B</scp>‐cell lymphoma in the rituximab eraReina Watanabe, Yoshiaki Ishigatsubo, Rika Ohshima et al.|European Journal Of Haematology|2013Cited by 58
European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patientsEri Yamamoto, Yoshiaki Ishigatsubo, Shin Fujisawa et al.|Cancer Science|2013Cited by 39
Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapyYuki Nakajima, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Medical Oncology|2014Cited by 15
Serum Beta-2 Microglobulin Level As a Useful Prognostic Marker Of Hodgkin LymphomaYuki Nakajima, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Blood|2013Cited by 4
Identification of Bone Marrow Involvement of FL: Comparison of PET-CT and Bone Marrow Biopsy.Yuki Nakajima, Hideaki Nakajima, Shin Fujisawa et al.|Blood|2016Cited by 2